Tanner Pharma Sustainability Profile
Tanner Pharma Group, commonly referred to as Tanner Pharma, is a leading provider of global access solutions for patients in need of critical medications. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, focusing on the pharmaceutical industry. Founded in 2008, Tanner Pharma has achieved significant milestones, including the development of innovative programmes that facilitate access to life-saving therapies. The company specialises in providing comprehensive services such as patient access programmes, clinical trial support, and supply chain management. What sets Tanner Pharma apart is its commitment to ensuring that patients receive the medications they require, regardless of geographical or financial barriers. With a strong market position and a reputation for excellence, Tanner Pharma continues to make a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does Tanner Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tanner Pharma's score of 20 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tanner Pharma's reported carbon emissions
In 2023, Tanner Pharma reported total carbon emissions of approximately 225,180 kg CO2e, with emissions distributed across various scopes: 21,150 kg CO2e from Scope 1, 5,420 kg CO2e from Scope 2, and a significant 198,610 kg CO2e from Scope 3. The Scope 3 emissions include about 23,720 kg CO2e attributed to employee-related activities and approximately 74,330 kg CO2e from upstream transportation and distribution. Tanner Pharma's emissions data is cascaded from its parent company, Tanner Pharma Group, Inc., reflecting a commitment to transparency in their environmental impact. However, the company has not set specific reduction targets or initiatives as part of their climate commitments. Overall, Tanner Pharma's emissions profile highlights the importance of addressing Scope 3 emissions, which constitute the majority of their carbon footprint, as they work towards enhancing their sustainability practices.
How Carbon Intensive is Tanner Pharma's Industry?
How Carbon Intensive is Tanner Pharma's Location?
Tanner Pharma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tanner Pharma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
